Kharasch E D, Bowdle T A
Department of Anesthesiology, University of Washington Medical Center, Seattle.
Anesth Analg. 1991 Feb;72(2):216-20. doi: 10.1213/00000539-199102000-00014.
We have observed that serum potassium levels measured immediately before induction of anesthesia ("preinduction K+") are often lower than those measured 1-3 days preoperatively ("preoperative K+"). The purpose of this investigation was to determine, in two studies, the magnitude of this difference and to elucidate the mechanism by which this occurs. In the first study, preinduction K+ (3.6 +/- 0.4 mEq/L, mean +/- SD) was significantly lower than K+ levels measured during routine preoperative testing (4.4 +/- 0.4 mEq/L, n = 47, P less than 0.001). Twenty-three patients (49%) had preinduction K+ levels that were considered hypokalemic (less than or equal to 3.5 mEq/L), but 22 of these 23 patients had normal preoperative K+ levels. The second study tested the hypothesis that preinduction decreases in serum K+ are mediated by beta 2-adrenergic receptors. Preinduction K+ changes were determined in patients given a single preoperative dose of propranolol (beta 1/beta 2-antagonist), atenolol (beta 1-antagonist), or no beta-blocker (control). The difference between preoperative and preinduction serum K+ in patients receiving propranolol (0.1 +/- 0.4 mEq/L) was significantly attenuated (P less than 0.02) compared with the difference in control subjects (0.5 +/- 0.4 mEq/L), but was not significantly different from controls in patients pretreated with atenolol (0.3 +/- 0.4 mEq/L). These results demonstrate that serum K+ levels measured intraoperatively just before anesthetic induction are consistently and significantly less than those measured 1-3 days preoperatively. The ability of propranolol but not atenolol to block this change suggests that the acute decrease in K+ levels was due to beta 2-adrenergic receptor stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)
我们观察到,在麻醉诱导前即刻测得的血清钾水平(“诱导前血钾”)往往低于术前1 - 3天测得的水平(“术前血钾”)。本研究的目的是通过两项研究确定这种差异的程度,并阐明其发生机制。在第一项研究中,诱导前血钾(3.6±0.4 mEq/L,均值±标准差)显著低于常规术前检查时测得的血钾水平(4.4±0.4 mEq/L,n = 47,P<0.001)。23例患者(49%)的诱导前血钾水平被认为是低钾血症(≤3.5 mEq/L),但这23例患者中有22例术前血钾水平正常。第二项研究检验了血清钾诱导前降低是由β2 - 肾上腺素能受体介导的这一假说。在术前单次给予普萘洛尔(β1/β2拮抗剂)、阿替洛尔(β1拮抗剂)或不给予β受体阻滞剂(对照组)的患者中测定诱导前血钾变化。与对照组(0.5±0.4 mEq/L)相比,接受普萘洛尔治疗的患者术前与诱导前血清钾的差异(0.1±0.4 mEq/L)显著减小(P<0.02),但与接受阿替洛尔预处理的患者(0.3±0.4 mEq/L)相比,与对照组无显著差异。这些结果表明,术中麻醉诱导前即刻测得的血清钾水平始终且显著低于术前1 - 3天测得的水平。普萘洛尔而非阿替洛尔能够阻断这种变化,提示血钾水平的急性降低是由于β2 - 肾上腺素能受体受刺激所致。(摘要截断于250字)